The Honda Prologue EV will live on, at least for now

Honda canceled plans to launch three new EVs in the U.S. this year (the Honda 0 Series SUV and Saloon, and the Acura RSX) and warned restructuring costs could reach ¥2.5 trillion (~$15.7B), signaling its first annual loss in nearly 70 years. The Prologue remains in the lineup for now, but sales are plunging (1,067 units last month, down ~63% from ~3,000 in Feb 2025), and Honda is offering up to $8,000 in sales credits and leases from $269/month while shifting focus back to hybrids amid weakened EV demand and policy headwinds.

Analysis

Honda’s pullback is a de facto re-pricing of platform risk across the OEM network: OEMs that own scalable EV stacks (GM, Tesla) gain optionality to squeeze licensing revenue and pick up spot volume without the headline-level R&D carry. Expect Ultium utilization conversations to accelerate — if GM can redeploy fixed costs across additional build partners, every incremental Honda-equivalent contract could move GM’s auto EBIT margin by 150–250bps over 12–24 months.

A second-order supply-chain effect is concentrated idleness in mid-tier EV suppliers (module integrators, Tier-2 battery pack assemblers) which have low switching costs but high fixed absorption needs; this increases price competition for cell and pack contracts and will compress supplier gross margins by 200–400bps within the next 6–12 months. Dealers and captives will lean into deeper retail incentives (we’re already seeing $5k–8k offers) which front-loads demand but pulls future residual values down — tightening lease-originated used-EV supply and pressuring ABS collateral performance in 12–36 months.

Macroeconomic and policy catalysts are binary and fast: a sharp gasoline rally (+30% in 60–90 days) or a reversal of EV incentive rollbacks would re-accelerate EV demand, while further regulatory easing or credit removal will extend the consolidation window. Time horizons split: tactically (days–weeks) price and incentive moves matter most for dealers and OEM Qs; strategically (12–36 months) platform ownership, cell contracts, and balance-sheet capacity determine winners and losers.

Key Decisions for Investors

• Long GM (equity) / buy 12-month LEAP calls: Entry on any >4% pullback in GM; target 30–45% upside if GM monetizes Ultium across 1–2 OEMs or demonstrates 150–250bps EBIT margin improvement; max downside = option premium, catalyst = GM partner announcements or better Utilization guidance within 6–12 months.
• Long TSLA via 6–9 month call spread (buy nearer-term ITM call, sell 20–30% OTM call): Entry within 2–6 weeks on stabilization in retail order flow; reward = capture consolidation of share with limited premium, risk = demand softness keeps spreads bid; target +40% gross on spread if competition retracts further and Tesla holds price discipline.
• Short LCID equity or buy 12-month puts: Initiate on any rally >10% as funding and scale risk reassert; thesis = capital intensity + softer demand -> 40–60% downside absent a large equity raise; time horizon 6–12 months, stop if company secures >$1bn committed liquidity.
• Long F (equity) on 3–6 month weakness: Entry after Ford reports next-quarter incentive-driven volume data; rationale = better near-term hedge vs hybrids/ICE transition and large scale EV investments providing optionality; target +20% in 6–12 months, risk = execution on new platforms and margin pressure from incentives.